WallStreetZenWallStreetZen

NASDAQ: CHRS
Coherus Oncology Inc Stock Ownership - Who owns Coherus Oncology?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Coherus Oncology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Dennis M. LanfearPresident CEO2026-01-2011,839$1.55
$18.35kSell
Bryan J. McMichaelChief Financial Officer2026-01-201,715$1.55
$2.66kSell

1 of 1

CHRS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CHRS insiders and whales buy or sell their stock.

CHRS Shareholders

What type of owners hold Coherus Oncology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc6.72%10,365,074$15.03MInstitution
Vsciences Investments Pte Ltd4.79%7,381,116$10.70MInsider
Vanguard Capital Management LLC3.54%5,452,762$7.91MInstitution
Samsara Biocapital LLC2.22%3,428,571$4.97MInstitution
Geode Capital Management LLC2.02%3,121,578$4.53MInstitution
Lilly Co Eli1.97%3,042,019$4.41MInsider
Kohlberg Kravis Roberts Co LP1.97%3,036,076$4.40MInstitution
Dennis M. Lanfear1.90%2,926,612$4.24MInsider
Daiichi Sankyo Company Ltd1.86%2,867,426$4.16MInsider
Kkr Biosimilar LP1.62%2,499,499$3.62MInsider

1 of 3

CHRS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CHRS38.43%14.02%Net Selling
CDXS46.96%53.04%Net SellingNet Selling
SLGL35.80%64.20%Net BuyingNet Buying
CLLS14.12%0.00%
OBIO36.71%63.29%Net BuyingNet Selling
View Top Biotech Stocks

Coherus Oncology Stock Ownership FAQ

Who owns Coherus Oncology?

Coherus Oncology (NASDAQ: CHRS) is owned by 38.43% institutional shareholders, 14.02% Coherus Oncology insiders, and 47.55% retail investors. Vsciences Investments Pte Ltd is the largest individual Coherus Oncology shareholder, owning 7.38M shares representing 4.79% of the company. Vsciences Investments Pte Ltd's Coherus Oncology shares are currently valued at $11.51M.

If you're new to stock investing, here's how to buy Coherus Oncology stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.